How Diphenhydramine (Benadryl) Causes Restless Legs Syndrome
Diphenhydramine causes restless legs syndrome primarily through its antihistaminergic and anticholinergic effects that interfere with dopaminergic neurotransmission in the central nervous system, though the exact mechanism remains incompletely understood.
Mechanism of Action
Antihistamines like diphenhydramine are well-established triggers for RLS 1, 2, 3. The pathophysiology involves:
- Dopaminergic disruption: Antihistamines interfere with dopamine receptor function and dopamine transmission in the brain, which is central to RLS pathogenesis 1, 2
- Central histaminergic effects: H1 receptor blockade in the CNS may disrupt the delicate balance between histamine, dopamine, and other neurotransmitter systems that regulate motor control and sensory processing 4
- Anticholinergic properties: Diphenhydramine's anticholinergic effects may further compound dopaminergic dysfunction
Clinical Evidence
The association between antihistamines and RLS is supported by multiple lines of evidence:
- Case reports and pharmacovigilance data consistently identify antihistamines as RLS triggers 5, 2, 6
- Patients with pre-existing RLS frequently report symptom exacerbation with antihistamine use 3
- Symptoms typically improve within days to weeks after discontinuing the offending agent 5
Important Clinical Considerations
Risk factors for drug-induced RLS include:
- Older age
- Higher medication doses
- Concurrent use of multiple RLS-triggering medications
- Pre-existing iron deficiency
- Gastrointestinal diseases 1
Common pitfall: The sedating properties of diphenhydramine often lead to its use as a sleep aid, but this can paradoxically worsen sleep quality in susceptible individuals by triggering or exacerbating RLS symptoms 3.
Management Approach
When diphenhydramine-induced RLS is suspected:
- Discontinue the medication immediately - this is the primary treatment 1
- Expect symptom resolution within 1-2 weeks of discontinuation 5
- Avoid substituting with other antihistamines, as they carry similar risk 5, 3
- Consider alternative treatments for the original indication (allergies, insomnia) that don't affect dopaminergic systems
If RLS symptoms persist after discontinuation, evaluate for underlying primary RLS or other contributing factors such as iron deficiency (ferritin, transferrin saturation) per current AASM guidelines 7.